Daluyon, Vanessa B.
HRN: 22-82-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2023
04/12/2023
IVTT
500 Mg
Q8
AGE With Mod DHN; Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes